Attention Administrator - database is in test mode!
Cannabidiol Does Not Convert to THC In Vivo
Although CBD Can Be Transformed to THC Under Acidic Conditions, the Conversion of Oral CBD Doesn’t Occur In Vivo
GEN Roundup: Top Trends in Tissue Engineering
The Ideal of Tissue Engineering Is Becoming More of a Reality
Human Neural Stem Cell Therapy for Chronic Ischemic Stroke
Charting Progress from Laboratory to Patients
Considering Sex as a Biological Variable in Biomedical Research
Factoring Sex into Research Designs, Analyses, and Scientific Study Reports
Bioethics of GM Humans
The Journal of the Royal Society of Medicine recently published two opposing viewpoints on the ethics of using gene-editing technology human embryos. One article, written by an actress who has a rare form of dwarfism, maintains that gene editing does not represent a benefit to healthcare. The other, written by an Oxford research fellow, makes the case that while gene editing is not without controversy it should be developed.
The first author makes the point that social inequality would increase between those who were and were not genetically modified. While the second author makes the distinction that gene editing embryos is about modifying life where it already existed versus artificial selection which chooses which embryo is allowed to continue developing.